相关实验视频

Updated: May 9, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

用聚沙林修改细胞外囊泡的表面,以增强它们的血稳定性和瘤积累

L Simon¹, J Constanzo², C Terraza-Aguirre³

¹ICGM, Montpellier University, CNRS, ENSCM, Montpellier, France.

|August 24, 2024

概括

聚氧素 (POxylation) 稳定了血中的细胞外囊泡 (EV),增强了它们的治疗潜力. 这种修改改善了EV半衰期和瘤积累,为基于EV的纳米疗法提供了对PEGylation的有希望的替代方案.

科学领域:

纳米医学是一种纳米医学.
生物技术是生物技术.
药物运输药物运输药物运输

背景情况:

细胞外囊泡 (EVs) 显示出治疗前景,但在体内存在不稳定性.
目前的战略往往侧重于电动汽车的准,忽视了改善生物分布的稳定.
开发稳定的隐形电动汽车对于推进基于电动汽车的纳米疗法至关重要.

研究的目的:

探索用脂质 (POxylation) 作为稳定EVs的一种方法的多氧化.
评估POxylation对EV血稳定性和生物分布的影响.
评估POxylation是否保留或增强介质干细胞/干细胞 (MSC) 衍生的EVs的原生性质.

主要方法:

使用带有脂质的多氧化 (POxylation) 的EV表面修饰.
在血中评估EV稳定性.
在体内追踪放射性标记的EVs在治疗度.
对于EV稳定和生物分布,POxylation与PEGylation的比较.

主要成果:

POxylation显著提高了EV在血中的稳定性,在注射后6小时半衰期增加了6倍.
通过POxylation,MSC衍生的EVs的免疫调节特性得到维持,并可能被增强.
在POxylation后,与PEGylation相比,瘤中的EV积累更高.

结论:

氧化是稳定细胞外囊泡的一种可行的策略,改善了它们的药理动力学特征.
这种方法为PEGylation提供了一个有希望的替代方案,用于开发基于EV的先进纳米疗法.
氧化增强了EV瘤的积累,并保留/增强了它们的治疗功能.

关键词:

电动汽车无线电标记外基因组是外基因组的组成部分.脂聚合物是一种脂聚合物.利波克萨索林的使用方法药理动力学药理动力学在插入后的插入.生物分销生物分销

更多相关视频

Evaluation of the Storage Stability of Extracellular Vesicles

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

Isolation and Analysis of Traceable and Functionalized Extracellular Vesicles from the Plasma and Solid Tissues

Isolation and Analysis of Traceable and Functionalized Extracellular Vesicles from the Plasma and Solid Tissues

Published on: October 17, 2022

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...